Guardant Health Inc’s recently made public that its Director Tariq Musa acquired Company’s shares for reported $6846.0 on Aug 19 ’25. In the deal valued at $59.02 per share,116 shares were bought.
Then, POTTER MYRTLE S bought 26 shares, generating $1,535 in total proceeds.
Before that, Tariq Musa sold 116 shares. Guardant Health Inc shares valued at $5,591 were divested by the Director at a price of $48.20 per share. As a result of the transaction, Tariq Musa now holds 7,324 shares, worth roughly $0.43 million.
Mizuho initiated its Guardant Health Inc [GH] rating to an Outperform in a research note published on April 10, 2025; the price target was $55. A number of analysts have revised their coverage, including Barclays’s analysts, who began to cover the stock in late January with a ‘”an Overweight”‘ rating. Guggenheim also remained covering GH and has increased its forecast on June 28, 2024 with a “Buy” recommendation from previously “Neutral” rating.
Price Performance Review of GH
On Tuesday, Guardant Health Inc [NASDAQ:GH] saw its stock fall -1.51% to $58.57. Over the last five days, the stock has gained 6.30%. Guardant Health Inc shares have risen nearly 105.22% since the year began. Nevertheless, the stocks have risen 91.72% over the past one year. While a 52-week high of $60.68 was reached on 08/14/25, a 52-week low of $20.14 was recorded on 01/02/25.
Levels Of Support And Resistance For GH Stock
The 24-hour chart illustrates a support level at 58.10, which if violated will result in even more drops to 57.63. On the upside, there is a resistance level at 59.48. A further resistance level may holdings at 60.39.
How much short interest is there in Guardant Health Inc?
A steep rise in short interest was recorded in Guardant Health Inc stocks on 2025-07-31, growing by 32864.0 shares to a total of 9.4 million shares. Yahoo Finance data shows the prior-month short interest on 2025-06-30 was 9.36 million shares. There was a rise of 0.35%, which implies that there is a positive sentiment for the stock.
